Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer
Clinical trial NCT04261179 · UNKNOWN
Trial details
- NCT number
- NCT04261179
- Sponsor
- Anna Cruceta
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2021-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.